Evidence map›Paper›PMID 39901995›Full record

ArticleCureus2025

Ovarian Angiosarcoma With Intractable Intraperitoneal Hemorrhage: A Case Report and Review of the Literature.

Naoki Tsuchiya, Yuichi Imai, Tamaki Cho, Yuki Ogawara, Taichi Mizushima, Hiroki Takase, Satoshi Fujii, Etsuko Miyagi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Naoki TsuchiyaObstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Yuichi ImaiObstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Tamaki ChoObstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Yuki OgawaraObstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Taichi MizushimaObstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Hiroki TakaseMolecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Satoshi FujiiMolecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.
Etsuko MiyagiObstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary ovarian angiosarcoma is an extremely rare malignant soft tissue tumor that arises from the vascular endothelium, with a limited number of reports. It has no specific symptoms, and it is rarely diagnosed in the early stages because of rapid progression. Furthermore, no standard drug therapy is available, and the prognosis is poor.  The patient was a 68-year-old woman suspected of having a ruptured ovarian tumor on plain abdominal computed tomography and anemia was observed. An emergency laparotomy was performed to stop the bleeding. Thereafter, one transcatheter arterial embolization, three laparotomies, and local radiotherapy were performed in an attempt to achieve hemostasis. However, the intraperitoneal bleeding remained intractable, and the transfusion was terminated after thorough consultation with the patient. The patient died 44 days after admission. Autopsy findings confirmed the diagnosis of primary ovarian angiosarcoma and pulmonary metastasis. Intractable intraperitoneal hemorrhage similar to that observed in this case has been reported, and because the prognosis is extremely poor, establishing an appropriate treatment regimen is desirable. Previously, the most commonly used drug regimens included anthracyclines and ifosfamide. However, recently, the possibility of treatment with molecular targeted agents and immune checkpoint inhibitors has been reported. In the future, case accumulation and genetic analyses will be required to establish appropriate treatment methods.

Indexed as

intraperitoneal hemorrhageliterature review of diseasenext generation sequencing (ngs)primary ovarian angiosarcomatherapy

Identifiers

PMID39901995
PMCPMC11788454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.